Skip to Content

Join the 'Uveitis' group to help and get support from people like you.

Uveitis Support Group

Summary

Our support group for Uveitis has 15 questions and 36 members. Updated 17 Aug 2018.

Popular Questions

View more questions...

Further Information

Related Condition Support Groups

Uveitis (Posterior), Uveitis (Anterior), Cyclitis, Panuveitis, Iritis

Related Drug Support Groups

methotrexate, cortisone, triamcinolone, sulfasalazine, Imuran, azathioprine, Durezol, TobraDex, homatropine, view more... Zylet, mycophenolate mofetil, infliximab, Maxitrol, fluocinolone, Kenalog-40, Acthar, Acthar Gel, HP, Acth, Azulfidine, cyclopentolate, Triesence, etanercept, Cyclogyl, Sulfazine, Isopto Homatropine, Maxidex, Blephamide, Poly-Dex, Azasan, loteprednol / tobramycin, dexamethasone / tobramycin, Ozurdex, Tobradex ST, hydrocortisone / neomycin / polymyxin b, Neo-Poly-Dex, Isopto Atropine, Ocu-Trol, Dexacine, AK-Trol, Medasulf, Methadex, Metimyd, Isopto Cetapred, Dexasporin, Sulster, AK-Cide, Supred, Cetapred, FML-S Liquifilm, Ocu-Lone C, Neo-Polycin HC, Neo-Poly-Bac, Neo / PolyB / HC, Ocu-Cort, Neotricin HC, AK-Dex, Decadron Ocumeter, Atropine-Care, Ocu-Dex, Trivaris, Cortomycin Suspension, Neo-Dexair, Dexacidin, Cortone Acetate, Neo-Dex, Blephamide SOP, corticotropin, dexamethasone / neomycin, dexamethasone / neomycin / polymyxin b, fluorometholone / sulfacetamide sodium, gentamicin / prednisolone, neomycin / polymyxin b / prednisolone, prednisolone / sulfacetamide sodium, rimexolone, difluprednate, Ak-Pentolate, Dexasol, FML-S, Vexol, Retisert, Vasocidin, AK-Neo-Dex, Ocu-Tropine, Neo-Decadron Ocumeter, Neo-Decadron, Pred-G, Pred-G SOP, Poly-Pred, Atrosulf-1, Atropisol, Homatropaire, Ocu-Pentolate, Pentolair, Cylate, Clinacort, bacitracin / hydrocortisone / neomycin / polymyxin b, Azulfidine EN-tabs, Yutiq

Popular Drugs for Uveitis

Related Condition Guides

Latest News

FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis

WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) – EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ...

Read more news...

Latest Questions

View more questions...

Top Group Members

suzanne66
11,336 total answers
Marvell
14,354 total answers
Howefelt...
16 total answers
sarah754
1 total answer
robo
3,753 answers
SHEsevEN4
1,085 answers

Ask a Question